含磺酰胺基团去氢枞醇氨基甲酸酯衍生物的合成及体外抗肿瘤活性
DOI:
CSTR:
作者:
作者单位:

桂林医学院药学院

作者简介:

通讯作者:

中图分类号:

TQ630

基金项目:

广西自然科学基金(2023GXNSFAA026277);桂林市科学研究与技术开发计划项目(20210227-1);广西林产化学与工程重点实验室开放课题资助项目(GXFK2202);广西药物分子发现与成药性优化重点实验室课题(GKLPMDDO-2022-P02);广西高等学校千名中青年骨干教师培育计划资助项目,桂林医学院硕士研究生科研项目(GYYK2023017),国家级大学生创新创业训练计划(202310601037)


Synthesis and antitumor activity of sulfonamide-substituted dehydroabietyl carbamate derivatives in vitro
Author:
Affiliation:

GuangxiKeyLaboratoryofDrugDiscoveryandOptimization,GuangxiEngineeringResearchCenterforPharmaceuticalMolecularScreeningandDruggabilityEvaluation,KeyLaboratoryofMedicalBiotechnologyandTranslationalMedicine,SchoolofPharmacy,GuilinMedicalUniversity

Fund Project:

Guangxi Natural Science Foundation (2023GXNSFAA026277); Guilin Scientific Research and Technology Development Program Project (20210227-1); Guangxi Key Laboratory of Forest Products Chemistry and Engineering Open Topic Funded Project (GXFK2202); Guangxi Key Laboratory of Drug Molecule Discovery and Optimization of Pharmacogenetic Properties Project (GKLPMDDO-2022-P02) ; funded project of Cultivation Program for Thousands of Young and Middle-aged Backbone Teachers in Guangxi Higher Education Institutions, Master"s Degree Research Project of Guilin Medical University (GYYK2023017), National Innovation and Entrepreneurship Training Program for Undergraduates (202310601037)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    为了寻找高效抗肿瘤活性分子,以去氢枞酸为原料,经三步反应合成了N-(氨基磺酰基)-4-去氢枞醇氨基甲酸酯类化合物。利用FT-IR、1HNMR、13CNMR和ESI-MS等方法对产物结构进行表征。以5-氟尿嘧啶作阳性对照,评价化合物对T-24、HepG2、MCF-7、MGC-803和Hela 5种肿瘤细胞株的体外抗肿瘤活性。结果表明部分化合物抗肿瘤活性优于阳性药,其中化合物IVd N-((2-溴苯基)氨基磺酰基)-4-去氢枞醇氨基甲酸酯对T-24细胞株的活性最好,其IC50值为14.64±0.46 μmol/L。利用Hoechst-33258染色、细胞集落形成、细胞周期分布、细胞凋亡和蛋白质印迹等实验研究其初步作用机制。结果表明化合物IVd明显抑制T-24细胞的生长,阻滞细胞周期于S期。此外,它还能下调抗凋亡蛋白Bcl-2的表达水平,上调促凋亡蛋白Bax的表达水平,从而促进T-24细胞发生凋亡。可见,引入氨基磺酰胺结构能够改善去氢枞酸骨架的抗肿瘤活性,值得进一步研究。

    Abstract:

    In order to find efficient anti-tumor active molecules,N-(aminosulfonyl)-4-dehydroabietyl carbamates compounds were synthesized from dehydroabietic acid via 3 step reaction and their structures were confirmed by FT-IR, 1HNMR,13CNMR, and ESI-MS. The antitumor activity against T-24, HepG2, MCF-7, MGC-803 and Hela tumor cell lines was evaluated using 5-fluorouracil as positive control. The results showed that the antitumor activity of some compounds was better than that of positive drugs, and compound IVd N-((2-bromophenyl) sulfamyl) -4-dehydroabietyl carbamate showed the best activity against T-24 cell line with IC50 value of 14.64±0.46μmol/L. The primary mechanism was studied by Hoechst 33258 staining, cell colony formation, cell cycle distribution, as well as cell apoptosis and western blotting. The results showed compounds IVd significantly inhibited the growth of T-24 cells and arrested the cell cycle in the S phase. In addition, it could promote T-24 cancer cells apoptosis through upregulation of proapoptotic ones Bax and downregulation of antiapoptotic protein Bcl-2 expression. It is evident that the introduction of sulfanilamide can improve the anti-tumor activity of dehydroabietic acid, which is worthy of further study.

    参考文献
    相似文献
    引证文献
引用本文

王德荣,庞富华,钱威,李芳耀.含磺酰胺基团去氢枞醇氨基甲酸酯衍生物的合成及体外抗肿瘤活性[J].精细化工,2024,41(11):

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-10-26
  • 最后修改日期:2024-02-04
  • 录用日期:2023-12-25
  • 在线发布日期: 2024-11-08
  • 出版日期:
文章二维码